ADMI
CVS icon

Albert D. Mason Inc’s CVS Health CVS Stock Holding History

Albert D. Mason Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$724K Sell
10,076
-47
-0.5% -$3.62K 0.47% 74
2025
Q4 		$803K Buy
10,123
+109
+1% +$8.59K 0.53% 70
2025
Q3 		$755K Sell
10,014
-225
-2% -$15.4K 0.49% 73
2025
Q2 		$706K Buy
10,239
+79
+0.8% +$5.18K 0.51% 75
2025
Q1 		$688K Buy
10,160
+725
+8% +$43.4K 0.47% 80
2024
Q4 		$424K Sell
9,435
-5,990
-39% -$336K 0.28% 104
2024
Q3 		$970K Buy
15,425
+224
+1% +$13.1K 0.62% 68
2024
Q2 		$898K Buy
15,201
+17
+0.1% +$1.06K 0.61% 73
2024
Q1 		$1.21M Buy
15,184
+49
+0.3% +$3.74K 0.75% 59
2023
Q4 		$1.2M Sell
15,135
-117
-0.8% -$8.33K 0.79% 58
2023
Q3 		$1.06M Buy
15,252
+50
+0.3% +$3.54K 0.77% 53
2023
Q2 		$1.05M Buy
15,202
+1,037
+7% +$73.8K 0.72% 59
2023
Q1 		$1.05M Sell
14,165
-409
-3% -$34.3K 0.73% 54
2022
Q4 		$1.36M Sell
14,574
-332
-2% -$32K 0.97% 38
2022
Q3 		$1.42M Buy
14,906
+49
+0.3% +$4.85K 1.14% 22
2022
Q2 		$1.38M Sell
14,857
-155
-1% -$15.1K 1.02% 30
2022
Q1 		$1.52M Sell
15,012
-158
-1% -$16.6K 0.98% 33
2021
Q4 		$1.56M Buy
15,170
+1,844
+14% +$170K 0.93% 37
2021
Q3 		$1.13M Buy
13,326
+65
+0.5% +$5.45K 0.73% 62
2021
Q2 		$1.11M Buy
13,261
+336
+3% +$27.5K 0.68% 71
2021
Q1 		$972K Buy
12,925
+1
+0% +$73 0.63% 69
2020
Q4 		$883K Buy
12,924
+971
+8% +$63.2K 0.61% 74
2020
Q3 		$698K Buy
11,953
+405
+4% +$25.2K 0.57% 73
2020
Q2 		$750K Sell
11,548
-115
-1% -$7.24K 0.63% 65
2020
Q1 		$692K Buy
11,663
+413
+4% +$27.6K 0.7% 63
2019
Q4 		$836K Buy
11,250
+530
+5% +$37.2K 0.59% 80
2019
Q3 		$676K Buy
10,720
+135
+1% +$8K 0.51% 89
2019
Q2 		$577K Buy
+10,585
New +$570K 0.43% 96

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Albert D. Mason Inc's CVS Position: Q1 2026 in Review

Albert D. Mason Inc reduced its CVS Health (CVS) stake by 0.46% in Q1 2026, selling an estimated $3.62K and leaving 10,076 shares worth $724K. The position accounts for 0.47% of the portfolio, ranked #74.

Albert D. Mason Inc first reported a position in CVS in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.56M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Albert D. Mason Inc held 10,076 shares of CVS Health worth $724K as of Q1 2026.
  • Albert D. Mason Inc sold 47 CVS Health shares in Q1 2026, an estimated $3.62K.
  • CVS Health made up 0.47% of Albert D. Mason Inc's portfolio in Q1 2026, its #74 holding.
  • Albert D. Mason Inc first reported a position in CVS Health in Q2 2019 and has held it in 28 quarters since.
  • Albert D. Mason Inc's CVS Health position peaked at $1.56M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Albert D. Mason Inc's 13F filing for Q1 2026, filed 15 Apr 2026.